Moderna, Inc.: Working Hard But Competition Is Working Harder
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Moderna Stock Falls After Vaccine Maker's Wider-Than-Expected Loss
Moderna shares fell after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, or $2.91 per share, ...
Moderna, Natwest, Fannie Mae set to report earnings Friday
Earnings season continues, and we're here to spotlight the companies expected to report their financial results on the next ...
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at $2.68 per share, versus earnings of 55 cents per share in the year-ago period. Moderna projects quarterly ...
Moderna, Inc. (NASDAQ:MRNA) Stake Lessened by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...
Why Moderna Inc. (MRNA) Crashed Last Week
We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...
1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Moderna
Inflation data, Powell testimony, more earnings will be in focus this week. • Robinhood’s strong financial health, robust ...